The nocebo effect: A reason for patients' non-adherence to generic substitution?

Institut für Gesundheitsökonomie und Klinische Epidemiologie, Köln, Germany.
Pharmazie (Impact Factor: 1). 07/2010; 65(7):451-6. DOI: 10.1691/ph.2010.9749
Source: PubMed

ABSTRACT Substituting generic formulations of the same chemical agent is a common practice in German health care on the basis of so called rebate contracts. The substitution of a medication may affect the patients' adherence or result in adverse events. While adverse events which may be caused by the pharmacological activity of the agent itself can be explained, some non-specific side effects cannot be substantiated referring to pharmacological factors. These adverse reactions are summarized under the term nocebo effect. Since patients experiencing a nocebo effect can subsequently become non-adherent or even discontinue an appropiate therapy, the aim of this article is to study patients' adherence to generic substitution and the extent of the nocebo effect. In MEDLINE and EMBASE, a search was carried out for articles which were published between March 25th, 1989 and March 25th, 2009 by using the following search terms: generic substitution, adherence, non-adherence, non-persistence, rebate contracts, patients' attitude, nocebo, negative placebo effects, placebo adverse reactions, placebo induced side effects and negative placebo responses. In addition a manual search was performed in the reference lists of the articles retrieved. 14 studies met the inclusion and exclusion criteria and were included in this article. The generic substitution was generally accepted by over two thirds of the study populations. But up to 34% of patients being treated for psychological diseases confronted with a change of their medication had additional adverse events. On the basis of the studies analysed, the conclusion can be drawn that the nocebo effect can play a crucial role in the treatment of psychological diseases. Therefore, physicians and pharmacists should be responsible to prevent the nocebo effect through adequately educating the patients.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A low level of compliance of prescribed treatments has a strong impact on the expected therapeutic results and constitutes a public health key issue. Objectives The aim of this survey was to evaluate prescriptions of analgesic treatments, patients compliance and to compare therapeutic strategies and patients attitudes towards these prescriptions. The impact of pain intensity: mild (MI), moderate (MO) or severe (SE) was evaluated too. Results In the group of SE more people were benefiting from prescription of analgesics and less was using over-the-counter (OTC) compounds. The average duration of prescriptions is more than 5 years (62.5 months). The average duration of prescription of strong opioids is about 35 months (MO: 33.6 and SE: 39.8 months) while that of weak opioids is from 38.8 (MI) to 66.2 (SE) months. That of NSAID also increased with pain intensity: 35.6 (MI) to 51.8 (SE) months. The average number of treatment days per month is 17 days with extremes of 30 days for tricyclic antidepressant drugs and of 12 days for NSAID. Only 43% of the people were “extremely” and “very satisfied” with prescribed treatments. Percentages of “complete compliance” were 27% in case of MI and 44% in case of SE. Patients were 51% to use strategies to reduce prescription costs and the number of concerned persons was increasing in parallel with the pain intensity. Finally, they were 9% to think that their prescriptions haven’t been modified, during the delivery, by the pharmacist. Conclusion Prescribed treatments increased with pain intensity, and according to etiologies responsible of pain, they were prescribed in the long term. The number of satisfied persons was low while in parallel number of non-compliant persons was high. Finally, they were many to look for solutions to lower prescription costs.
    Douleurs Evaluation - Diagnostic - Traitement 06/2013; 14(3):119–130. DOI:10.1016/j.douler.2013.03.008
  • [Show abstract] [Hide abstract]
    ABSTRACT: Placebo and nocebo effects are often regarded by clinicians as either a quaint reminiscence from the pre-therapeutic era, or simply as a technique for establishing the efficacy of therapeutic interventions within the locus of evidence-based practice. However, neither of these explanations sufficiently account for their complexity or their persistence and impact in clinical medicine. Placebo and nocebo effects are embedded in the very fabric of therapeutic relationships and are both a manifestation and outcome of the rituals that characterise clinical practice. They are also a stark reminder of the many personal and environmental factors, including the attitudes, beliefs and expectations of both doctor and patient, that shape the outcomes of health professional-patient interactions. We describe how recent biological and neuropsychiatric data have clarified the operation of placebo and nocebo effects in clinical practice - demonstrating the ability of the therapeutic context to modulate endogenous biological processes in a targeted manner. This, in turn, illustrates the potent philosophical and sociocultural aspects of medical praxis.
    Internal Medicine Journal 04/2014; 44(4):398-405. DOI:10.1111/imj.12380 · 1.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ZUSAMMENFASSUNG Hintergrund: Nocebophänomene kommen im klinischen Alltag häufig vor. Ihre Bedeutung für das ärztliche Handeln wird von Grundlagenwissenschaftlern, Kli-nikern und Ethikern in den letzten Jahren zunehmend erforscht und diskutiert. Methode: Es erfolgte eine selektive Literaturrecherche in der Datenband Pub-Med mit den Suchbegriffen "nocebo" oder "nocebo effect" für Artikel, die bis Dezember 2011 veröffentlicht wurden. Ergebnisse: Noceboeffekte sind Beschwerden, die unter einer Scheinbehand-lung und/oder durch Suggestion negativer Erwartungen entstehen. Unter einer Noceboantwort versteht man Beschwerden, die durch negative Erwartungen des Patienten und/oder Suggestionen der Behandler ohne eine Behandlung er-zeugt werden. Zugrundeliegende Mechanismen sind Lernen durch Pawlowsche Konditionierung und Reaktion auf Erwartungen, ausgelöst durch verbale Infor-mationen oder Suggestionen. Noceboantworten können durch unbeabsichtigte negative Suggestionen von Ärzten und Pflegepersonal hervorgerufen werden. Die Aufklärung über mögliche Komplikationen einer Therapie und negative Er-wartungen des Patienten erhöhen die Häufigkeit unerwünschter Wirkungen. Ein Teil der subjektiven unerwünschten Wirkungen von Medikamenten sind auf Noceboeffekte zurückzuführen. Schlussfolgerungen: Ärzte befinden sich in dem ethischen Dilemma zwischen der Pflicht, den Patienten über mögliche Nebenwirkungen einer Behandlung zu informieren und der Pflicht, die Risiken eines medizinischen Eingriffs für den Patienten zu minimieren, das heißt auch die Induktion von Noceboeffekten durch eine Aufklärung zu vermeiden. Mögliche Strategien der Lösung dieses Dilemmas sind die Fokussierung auf die Verträglichkeit von Maßnahmen sowie das durch den Patienten erlaubte Verschweigen von unerwünschten Wirkungen im Aufklärungsgespräch. Ein Kommunikationstraining während des Medizin-studiums und in der ärztlichen Fort-und Weiterbildung ist sinnvoll, um die "Macht der Worte" des Arztes zum Nutzen des Patienten einzusetzen und Schaden von ihm abzuwenden. ►Zitierweise Häuser W, Hansen E, Enck P: Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int 2012; 109(26): 459–65.

Full-text (2 Sources)

Available from
Jan 8, 2015